The Translational and Clinical Resource Core (TRAC Core) of the AACORT was developed to expedite the translation of the insight we have gained into AA pathogenesis from our GWAS and immunological studies into novel effective treatments. By facilitating seamless access to biosamples from a well-defined patient population, and supporting researchers with services to enhance scientific rigor, the TRAC Core is positioned to facilitate the progress of translational investigation of AA pathophysiology and treatment.